Related Experiment Video
Updated: Jul 20, 2025
07:50
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.7K
Tetracycline antibiotics: Potential anticancer drugs
Jiayu Li1, Yuan Qin2, Chenhao Zhao1
1College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
European Journal of Pharmacology
|August 4, 2023
Summary
FDA-approved tetracycline antibiotics like doxycycline show anticancer properties, inhibiting cancer progression and metastasis. These drugs can be combined with chemotherapy to improve patient survival and quality of life.
Area of Science:
- Oncology
- Pharmacology
Background:
- Tetracycline antibiotics, initially known for antibacterial properties, are increasingly studied for anticancer effects.
- Doxycycline, minocycline, and tigecycline are FDA-approved tetracyclines with demonstrated anticancer potential.
Purpose of the Study:
- To review the anticancer mechanisms of doxycycline, minocycline, and tigecycline.
- To explore their efficacy in combination therapies for various cancers.
- To summarize their role as adjuvant drugs in clinical cancer treatment.
Main Methods:
- Literature review of studies on tetracycline antibiotics and cancer.
- Analysis of mechanisms of action including anti-proliferation, anti-metastasis, autophagy, and apoptosis.
- Examination of combination therapy data with chemotherapy and targeted drugs.
Main Results:
- Doxycycline, minocycline, and tigecycline exhibit anticancer activities through multiple pathways.
- These tetracyclines show promise in combination therapies to inhibit cancer progression.
- They can alleviate side effects and improve survival in patients undergoing chemotherapy.
Conclusions:
- Doxycycline, minocycline, and tigecycline represent a promising class of drugs with dual antibacterial and anticancer functions.
- Further research into their mechanisms and clinical applications could enhance cancer treatment strategies.
- Identifying research gaps and future directions is crucial for optimizing their therapeutic use.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K